Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Comparison of Generic vs Brand Tacrolimus in Renal Transplant
NCT01256294Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2010
- Primary completion
- May 2011
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplant rejection, sponsored by Novartis. Started Oct 2010; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01256294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01256294.